 |
市場調查報告書
商品編碼
1935314
皮癬菌症/甲癬治療市場按產品類型、治療方法、最終用戶和地區分類Dermatophytic Onychomycosis Treatment Market, By Product Type, By Treatment, By End User, By Geography |
||||||
價格
簡介目錄
預計到 2026 年，皮癬菌甲癬治療市場價值將達到 72.966 億美元，預計到 2033 年將達到 122.197 億美元，2026 年至 2033 年的年複合成長率（CAGR）為 7.6%。
| 報告覆蓋範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2025 | 2026年市場規模： | 72.966億美元 |
| 歷史數據時期： | 2020年至2024年 | 預測期： | 2026年至2033年 |
| 預測期（2026-2033年）複合年成長率： | 7.60% | 預計2033年價值： | 122.197億美元 |
甲癬是一種由紅色毛癬菌或須癬毛癬菌引起的真菌感染疾病，有時也可能由酵母菌或黴菌引起。甲癬的主要原因是接觸昆蟲增多和潮濕環境，這些因素為真菌生長創造了理想的條件。甲癬的主要症狀包括指甲下方出現白色或黃色斑點、指甲增厚、指甲邊緣碎裂。
本次調查的主要特點
- 本報告對全球皮癬菌甲癬治療市場進行了詳細分析，以 2025 年為基準年，給出了預測期（2026-2033 年）的市場規模和復合年成長率（%）。
- 該報告還重點介紹了各個細分市場的潛在商機，並概述了該市場具有吸引力的投資提案矩陣。
- 該研究還提供了有關市場促進因素、限制因素、機會、新產品發布或核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
- 本報告根據以下參數介紹了全球皮癬菌甲癬治療市場主要企業的概況：公司概況、財務表現、產品系列、市場地位、分銷策略、主要發展、策略和未來計劃。
- 本報告的研究結果將幫助負責人和經營團隊就即將推出的產品、技術升級、市場擴張和行銷策略做出明智的決策。
- 這份全球皮癬菌甲癬治療市場報告的目標對象包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
- 相關人員將能夠透過用於分析全球皮癬菌甲癬治療市場的各種策略矩陣輕鬆做出決策。
目錄
第1章 研究目標與前提條件
- 調查目的
- 先決條件
- 簡稱
第2章 市場範圍
- 報告概述
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章 市場動態、監理及趨勢分析
- 市場動態
- 促進要素
- 抑制因素
- 市場機遇
- 影響分析
- 市場趨勢
- 重大進展
- 法規環境
- 救贖方案
- 併購趨勢
- PEST分析
4. 2026-2033年全球皮癬菌甲癬治療市場（依產品類型分類）
- 藥片
- 指甲油
5. 2026-2033年全球皮癬菌症/甲癬治療市場（依治療方法）
- 口服
- 外用
6. 2026-2033年全球皮癬菌甲癬治療市場（依最終用戶分類）
- 醫院
- 診所
- 獨立藥房
- 郵購藥房
- 藥局
7. 2026-2033年全球皮癬菌症/甲癬治療市場（依地區分類）
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
- 歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 俄羅斯
- 其他歐洲
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 亞太其他地區
- 中東
- GCC
- 以色列
- 其他中東地區
- 非洲
- 南非
- 中非
- 北非
第8章 競爭情勢
- 熱圖分析
- 市佔率分析
- Valeant Pharmaceuticals International Inc.
- Galderma SA
- Novartis AG
- Pfizer Inc.
- Moberg Pharma AB
- Janssen Global Services, LLC（Johnson &Johnson Services, Inc.）
- Anacor Pharmaceuticals, Inc.
- NovaQuest Capital Management, LLC
- Novan, Inc.
第9章各節
- 參考
- 調查方法
簡介目錄
Product Code: CMI2053
Dermatophytic Onychomycosis Treatment Market is estimated to be valued at USD 7,296.6 Mn in 2026 and is expected to reach USD 12,219.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 7,296.6 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.60% | 2033 Value Projection: | USD 12,219.7 Mn |
Nail onychomycosis is a fungal infection is caused by a trichophyton rubrum, trichophyton mentagrophytes, and in some cases it is caused by yeasts and molds. The major factors responsible for nail onchomycosis infection is increased exposure to worm and moist environment which leads to perfect condition for fungus to grow and proliferate. The major symptoms of onychomycosis comprises of white and yellow spots under the nail leading to discoloration, nail thickening, and formation of crumbling edges on the nail.
Key features of the study
- This report provides in-depth analysis of the global dermatophytic onychomycosis treatment market and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global dermatophytic onychomycosis treatment market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include Valeant Pharmaceuticals International Inc., Galderma S.A., Novartis AG, Pfizer Inc., Moberg Pharma AB, Janssen Global Services, LLC (Johnson & Johnson Services, Inc.), Anacor Pharmaceuticals, Inc., NovaQuest Capital Management, L.L.C., and Novan, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- The global dermatophytic onychomycosis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global dermatophytic onychomycosis treatment market
Market Segmentation
- By Product Type
- Tablets
- Nail Paints
- By Treatment
- Oral
- Topical
- By End User
- Hospitals
- Clinics
- Independent Pharmacies
- Mail Order Pharmacies
- Drug Stores
- By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
- Global Dermatophytic Onychomycosis Treatment Market: Competitive Landscape
- Valeant Pharmaceuticals International Inc.
- Galderma S.A.
- Novartis AG
- Pfizer Inc.
- Moberg Pharma AB
- Janssen Global Services, LLC (Johnson & Johnson Services, Inc.)
- Anacor Pharmaceuticals, Inc.
- NovaQuest Capital Management, L.L.C.
- Novan, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Treatment
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Reimbursement Scenario
- Merger and Acquisition Scenario
- PEST Analysis
4. Global Dermatophytic Onychomycosis Treatment Market, By Product Type, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2019 and 2033 (%)
- Y-o-Y Growth Analysis, 2017 - 2033
- Segment Trends
- Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Nail Paints
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
5. Global Dermatophytic Onychomycosis Treatment Market, By Treatment, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2019 and 2033 (%)
- Y-o-Y Growth Analysis, 2017 - 2033
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
6. Global Dermatophytic Onychomycosis Treatment Market, By End User, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2019 and 2033 (%)
- Y-o-Y Growth Analysis, 2017 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Independent Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Mail Order Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Drug Stores
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
7. Global Dermatophytic Onychomycosis Treatment Market, By Region, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2019 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2033
- North America
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Treatment, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Treatment, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Treatment, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Treatment, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Treatment, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Treatment, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
- South Africa
- Central Africa
- North Africa
8. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Valeant Pharmaceuticals International Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Galderma S.A.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novartis AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Moberg Pharma AB
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Janssen Global Services, LLC (Johnson & Johnson Services, Inc.)
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Anacor Pharmaceuticals, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- NovaQuest Capital Management, L.L.C.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novan, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Analyst Views
- Valeant Pharmaceuticals International Inc.
9. Section
- References
- Research Methodology
- About Us and Sales Contact
